Latest News

Are you 18 or over? Do you wear contact lenses?

Are you over 18 years old and interested in participating in clinical trials? If ‘yes’ the Brien Holden Vision Institute is seeking volunteers who are experienced contact lens wearers for a clinical trial involving daily disposable contact lenses. The trial aims to compare the clinical performance and participant experience of a new daily disposable contact lens,

Read More »

Cycloplegic Refraction in Managing Myopia

Rebecca Yan Shun Weng, BOptom (Hons), GradDip (I&T) BHVI The prevalence of myopia has increased dramatically, with an observable trend of earlier myopia onset in school-aged children.1,2 It is known that younger myopic children are prone to greater annual progression3,4, hence they are likely to progress to higher levels of myopia, leading to an increased risk of

Read More »

Our Purpose

We fulfil unmet needs in the ophthalmic space by innovating commercially relevant technologies through to feasibility.

We generate ideas.  We push the scientific envelope.  We solve problems.  We translate and communicate our knowledge. We look forward.

Our Values


We focus exclusively on research, development and ophthalmic sector support.


We lead with industry, solving problems and creating technology. We bring new ideas to markets.


We focus on meeting unmet needs. We trial, test, learn, share and adapt. 


We cannot achieve without each other; our team, our partners and our customers.

Learn myopia management with BHVI.

So the next generation can keep

A myopia patient is a lifelong patient.

BHVI’s world leading Myopia Education Program brings you the latest research, clinical procedures, and business expertise.

Copyright © Brien Holden Vision Institute (ABN 49 081 303 282) Brien Holden Vision Institute Foundation (ABN 86 081 872 586). All Rights Reserved.

Bausch Health And BHVI Announce Exclusive Global Licensing Agreement For Myopia Control Contact Lens

SYDNEY, Australia and LAVAL, Quebec, Oct. 15, 2020 – Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and Bausch + Lomb, its leading global eye health business, along with BHVI, an Australian not-for-profit organization with an international focus on vision research, announced today that an affiliate of Bausch Health has acquired an exclusive license for a myopia control contact lens design developed by BHVI. Bausch + Lomb will pair BHVI’s novel contact lens design with its leading contact lens technologies to develop potential contact lens treatments designed to slow the progression of myopia in children.

Our site uses cookies. By continuing to use this website, you agree to their use. For more details, please check our Privacy Policy.